OAM
FATE icon

Oxford Asset Management’s Fate Therapeutics FATE Stock Holding History

Oxford Asset Management’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-41,289
Closed -$530K – 1754
2018
Q4 		$530K Buy
+41,289
New +$576K 0.01% 1172
2017
Q4 		– Sell
-78,126
Closed -$318K – 1689
2017
Q3 		$318K Sell
78,126
-15,457
-17% -$52.6K 0.01% 1328
2017
Q2 		$303K Buy
+93,583
New +$359K 0.01% 1255
2016
Q1 		– Sell
-51,745
Closed -$173K – 832
2015
Q4 		$173K Buy
+51,745
New +$217K ﹤0.01% 810

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return